Afshin Azadikhah
Papers
1
Total Citations
62
H-Index
1
About
Afshin Azadikhah is a leading researcher in prostate cancer imaging, specializing in advanced microstructural MRI techniques. His primary research focuses on developing and validating diffusion-relaxation correlation spectrum imaging (DR-CSI) to improve the noninvasive characterization of prostate cancer. His most cited work, a 2020 study published in *Radiology*, demonstrated the first rigorous validation of DR-CSI against whole-mount digital histopathology using 3-T MRI. This landmark paper, with 62 citations, established a critical link between microstructural MRI signals and actual tissue architecture, showing that DR-CSI can differentiate cancerous from benign prostate tissue with high specificity. By correlating imaging biomarkers with histopathological ground truth, Azadikhah’s research provides a foundation for more accurate, noninvasive prostate cancer diagnosis and grading. His work addresses a key gap in the field—the lack of histopathological validation for advanced diffusion MRI methods—and has significant implications for reducing unnecessary biopsies and improving treatment planning. Azadikhah’s contributions are advancing the clinical translation of microstructural imaging, positioning him as a key figure in the evolution of prostate cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1